Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM)

Cancers - Switzerland
doi 10.3390/cancers11081137
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Comparative Analysis of Different Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer

Tumors of female reproductive system
2017English

Management of Metastatic Colorectal Cancer Patients: Guidelines of the Italian Medical Oncology Association (AIOM)

ESMO Open
Cancer ResearchOncology
2017English

The Role of Epidermal Growth Factor Receptor (EGFR) in the Efficacy of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients

Bulletin of Siberian Medicine
Molecular Medicine
2020English

Development of a Vaccine Targeting Triple-Negative Breast Cancer

2013English

Non-Platinum Metal Complexes as Potential Anti-Triple Negative Breast Cancer Agents

Crystals
Materials ScienceInorganic ChemistryChemical EngineeringCondensed Matter Physics
2018English

Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer

New England Journal of Medicine
Medicine
2012English

CD44v9 as a Poor Prognostic Factor of Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy

Breast Cancer
Nuclear MedicineRadiologyPharmacologyOncologyImagingMedicine
2018English

Development and Validation of Nomograms Predicting Survival in Chinese Patients With Triple Negative Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Association of PTP1B With Outcomes of Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy

Breast Cancer: Basic and Clinical Research
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy